Mauricio Castaño

Dr. Mauricio Castaño

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in Revista Colombiana de Psiquiatría
Verified
Journal Article
Closed access
MCMauricio Castaño
Mauricio Castaño
JSJuan Carlos Sepúlveda-Arias
Juan Carlos Sepúlveda-Arias
KDKelly Duica
Kelly Duica
AZAna M. Díaz Zuluaga
Ana M. Díaz Zuluaga
CVCristian Vargas
Cristian Vargas
CLCarlos López-Jaramillo
Carlos López-Jaramillo

1 January 2015 in Revista Colombiana de Psiquiatría
Verified
Journal Article
Closed access
MCMauricio Castaño
Mauricio Castaño
YRYeferson André Martínez Ramírez
Yeferson André Martínez Ramírez
FMFelipe Marulanda Mejía
Felipe Marulanda Mejía
RCRicardo Díaz Cabezas
Ricardo Díaz Cabezas
LSLenis Alexandra Valderrama Sánchez
Lenis Alexandra Valderrama Sánchez
DADaniel Camilo Aguirre Acevedo
Daniel Camilo Aguirre Acevedo

18 April 2023 in Life
Verified
Journal Article
Open access
PDF file
CICarlos Isaza
Carlos Isaza
MCMauricio Castaño
Mauricio Castaño
JVJuan Pablo Vélez
Juan Pablo Vélez
JHJulieta Henao
Julieta Henao
LALeonardo Beltran Angarita
Leonardo Beltran Angarita
JSJuan Carlos Sepúlveda-Arias
Juan Carlos Sepúlveda-Arias
Methadone treatment reduces the use of heroin and withdrawal symptoms; however, methadone is an expensive medication with a narrow safety margin. We compared the retention rates, persistence of heroin use, and quality of life of a group of patients undergoing conventional Methadone Maintenance Treatment (MMT) with a group for whom the CYP2B6 516G>T polymorphism was used in addition to the MMT to calculate the required methadone dose. Over 12 weeks, the retention rate, heroin usage, and quality of life of patients under conventional treatment (n = 34) were compared with those of patients for whom we used genetic markers to calculate methadone dosage (n = 38). At the end of the study, 26.4% of patients abandoned the program, and neither demographic nor clinical variables were associated with treatment adherence. Of the remaining patients, 16% of the control group and 8% of patients in the pharmacogenetic group reported heroin use, while both groups showed a 64% reduction in the use of cocaine/crack (no significant differences between the groups were found). Starting in the second week, the methadone dosage was lower among the patients for whom methadone was prescribed based on genotype. Although there were six individuals in the control group and three in the pharmacogenetic group with QTc intervals > 450 ms (a threshold that is considered dangerous), we did not find a relationship between the QTc interval and methadone dosage. There were no differences in the perception of quality of life between the two groups. The results of this pilot study suggest that concerning methadone therapy, the CYP2B6 genotype contributes to reduced effective doses and treatment costs.

13 October 2025 in Psychological Medicine
Verified
Journal Article
Open access
PDF file
GGGreta Gerdes
Greta Gerdes
JSJanet Song
Janet Song
SSSusan K. Service
Susan K. Service
ARAna M. Ramirez-Diaz
Ana M. Ramirez-Diaz
ADAna M. Diaz-Zuluaga
Ana M. Diaz-Zuluaga
LLLoes Olde Loohuis
Loes Olde Loohuis
Background: Despite growing healthcare coverage, disparities in access to and outcomes of psychiatric care persist, even in countries with universal healthcare. How socioeconomic status (SES), travel time, and social support individually and jointly affect psychiatric clinical trajectories remains largely unexplored. Methods: We analyze electronic health records (EHRs) from patients diagnosed with bipolar disorder, major depressive disorder, or schizophrenia at Clínica San Juan de Dios Manizales. Using zero-inflated and standard negative binomial regression, we quantify the effects of SES, travel time, and family/social support on utilization, clinical outcomes, and symptoms of mania, psychosis, and suicidality. A mixed-effects model examines how care-seeking patterns affect visit-to-visit variability in outcomes. Results: Among 21,095 patients, utilization is lower for those with low SES (rate ratio [RR] 0.92, 95% CI: 0.90–0.95, p = 1.27e−10) and longer travel times (RR 0.94, 95% CI: 0.93–0.95, p = 1.19e−53). Patients with low SES are more likely to have severe symptoms (e.g., delusions: RR 1.28, 95% CI: 1.20–1.37, p = 2.57e−15) and require hospitalization (RR 1.10, 95% CI: 1.05–1.15, p = 1.94e−04), suggesting they primarily seek care when critical. Longer travel differentially affects those with low SES. However, the relationship between SES and adverse outcomes is less pronounced when living with family (e.g., hospitalizations: LRT, χ2 = 47.08, df = 3, p = 3.35e−10). Frequent outpatient care is associated with lower odds of hospitalization, suicidality, and other symptoms. Conclusions: Findings demonstrate use of EHRs to model patient outcomes, the important role of social support, and need for improved healthcare accessibility.

17 March 2025 in Colombia Medica
Verified
Journal Article
Open access
PDF file
CZCarolina González Zapata
Carolina González Zapata
MCMauricio Castaño
Mauricio Castaño
JLJairo Franco Londoño
Jairo Franco Londoño
JOJuan Carlos Medina Osorio
Juan Carlos Medina Osorio
JSJennifer Nessim Salazar
Jennifer Nessim Salazar
AFAndrés Fandiño-Losada
Andrés Fandiño-Losada
Objetivo: Identificar los factores demográficos, psicosociales y del ciclo de vida que aumentan el riesgo de suicidio en la zona cafetera de Colombia entre la segunda mitad de 2017 y finales de 2019.Métodos: Diseño de casos y controles emparejados. Se utilizó una muestra de 176 personas, de las cuales 101 eran muertes por suicidio (casos) y 75 eran muertes por accidentes de tránsito (controles); se utilizaron autopsias psicológicas con fines de investigación. Se realizaron análisis de regresión logística de máxima verosimilitud penalizada, que indicaban la oportunidad o ventaja relativa (OR) de suicidio, ajustando por sexo, grupo de edad, provincia de la autopsia médico-legal y fuente de los datos. Las regresiones logísticas se aplicaron en tres bloques: problemas de salud mental, consumo de sustancias psicoactivas y adversidades durante el curso de la vida. El análisis estadístico se realizó con Stata®.Resultados: El 78.2 % de los casos y el 84.0 % de los controles eran hombres. La edad media de los casos era de 39 años y la de los controles, de 43 años. Los factores de riesgo clave para el suicidio, con p< 0,05, fueron el trabajo forzoso durante la adolescencia (OR: 32,41), la dependencia económica (OR: 4,3), el maltrato verbal o físico por parte de la pareja (OR: 10,28), cualquier trastorno mental (OR: 26,14), un intento previo de suicidio (OR: 11,64; p= 0.061) y antecedentes de trastorno depresivo mayor (OR: 24.86). Un factor protector fue la muerte de un familiar cercano en algún momento de la vida (OR: 0.34; p= 0.073).Conclusiones: El trabajo forzado en la adolescencia, el abuso verbal y físico por parte de la pareja, la dependencia económica de otras personas, cualquier trastorno mental, el trastorno depresivo severo y los intentos de suicidio previos fueron factores de riesgo de suicidio; la muerte de cualquier familiar cercano en algún momento de la vida fue un factor de protección contra el suicidio.

23 June 2025 in The British Journal of Psychiatry
Verified
Journal Article
Open access
PDF file
JHJuan F. De la Hoz
Juan F. De la Hoz
AAAlejandro Arias
Alejandro Arias
SSSusan K. Service
Susan K. Service
MCMauricio Castaño
Mauricio Castaño
ADAna M. Díaz-Zuluaga
Ana M. Díaz-Zuluaga
LLLoes Olde Loohuis
Loes Olde Loohuis
Background: Electronic health records (EHRs), increasingly available in low- and middle-income countries (LMICs), provide an opportunity to study transdiagnostic features of serious mental illness (SMI) and its trajectories. Aims: Characterise transdiagnostic features and diagnostic trajectories of SMI using an EHR database in an LMIC institution. Method: We conducted a retrospective cohort study using EHRs from 2005–2022 at Clínica San Juan de Dios Manizales, a specialised mental health facility in Colombia, including 22 447 patients with schizophrenia (SCZ), bipolar disorder (BPD) or severe/recurrent major depressive disorder (MDD). Using diagnostic codes and clinical notes, we analysed the frequency of suicidality and psychosis across diagnoses, patterns of diagnostic switching and the accumulation of comorbidities. Mixed-effect logistic regression was used to identify factors influencing diagnostic stability. Results: High frequencies of suicidality and psychosis were observed across diagnoses of SCZ, BPD and MDD. Most patients (64%) received multiple diagnoses over time, including switches between primary SMI diagnoses (19%), diagnostic comorbidities (30%) or both (15%). Predictors of diagnostic switching included mentions of delusions (odds ratio = 1.47, 95% CI 1.34–1.61), prior diagnostic switching (odds ratio = 4.01, 95% CI 3.7–4.34) and time in treatment, independent of age (log of visit number; odds ratio = 0.57, 95% CI 0.54–0.61). Over 80% of patients reached diagnostic stability within 6 years of their first record. Conclusions: Integrating structured and unstructured EHR data reveals transdiagnostic patterns in SMI and predictors of disease trajectories, highlighting the potential of EHR-based tools for research and precision psychiatry in LMICs.